Rx for trunchal acne with post inflammatory hyperpigmentation
Reading File
Finding Sources
Finding Sources
Searching PubMed
truncal acne treatment topical
Reading File
Finding Sources
Searching PubMed
post-inflammatory hyperpigmentation acne treatment
Reading File
Finding Sources
Finding Sources
Reading Article
PMID: 37843491
Finding Sources
Finding Sources
Searching the Web
truncal acne post inflammatory hyperpigmentation treatment guidelines 2024
Reading Web Page
https://acneandrosacea.org/wp-content/uploads/2024/11/Conte-…
Finding Sources
Here is a comprehensive prescription framework for truncal acne with post-inflammatory hyperpigmentation (PIH):
Truncal Acne + Post-Inflammatory Hyperpigmentation: Treatment Rx
Step 1 - Treat Active Acne First (This Prevents New PIH)
The backbone is the same as facial acne. Topical medications should be applied to the entire acne-prone region on the trunk, not as spot treatment. Allow 6-8 weeks before judging response.
Topical Anti-Acne (apply to entire trunk, OD)
| Severity | First-Line Regimen |
|---|---|
| Mild | Topical retinoid ± BPO wash/leave-on |
| Mild-Moderate | Topical retinoid + BPO (± topical antibiotic) |
| Moderate-Severe | Topical retinoid + BPO + oral antibiotic |
| Severe/Nodular | Above + isotretinoin consideration |
Note on truncal acne specifically: Back and chest lesions respond less robustly than facial lesions - isotretinoin doses up to 2 mg/kg/day may be needed for very severe truncal disease. - Fitzpatrick's Dermatology, block 13
Preferred retinoid for trunk (FDA-approved for truncal acne):
- Trifarotene 0.005% cream (Aklief) - 4th generation RAR-γ selective retinoid, approved specifically for facial AND truncal acne (age ≥9 in US, ≥12 in Canada). Has direct evidence for reducing acne-induced PIH. Apply OD to face and/or trunk.
- Alternatives: adapalene 0.1% or 0.3% gel, tretinoin cream/gel
BPO:
- 5-10% wash (leave on 2-3 min before rinsing) - practical for large truncal surface area
- Or leave-on BPO 2.5-5% gel applied to affected areas
Important caveat: BPO can bleach clothing and fabrics - counsel patients specifically about this for truncal use.
Step 2 - Address Post-Inflammatory Hyperpigmentation Simultaneously
PIH persists >1 year in ~50% of acne patients and >5 years in 22% - it warrants dedicated treatment alongside acne control.
Topical agents that address both acne AND PIH (dual-purpose):
| Agent | Acne Action | PIH Action | Notes |
|---|---|---|---|
| Topical retinoid (trifarotene, adapalene, tretinoin) | Anti-comedonal, anti-inflammatory | Accelerates epidermal turnover, disperses melanin granules | Backbone for both |
| Azelaic acid 15-20% | Antibacterial, anti-comedonal | Competitive tyrosinase inhibitor; selectively reduces abnormal melanocytes | Particularly useful; conditionally recommended by 2024 AAD guideline |
| Niacinamide 4-5% (OTC) | Mild anti-inflammatory | Blocks melanosome transfer from melanocytes to keratinocytes | Can be layered with retinoid |
| BPO 2.5-5% | Antibacterial | Mild keratolytic; can help fade superficial PIH | Best combined with retinoid |
Dedicated depigmenting agents (add-on if PIH is prominent):
- Hydroquinone 2-4% - gold standard tyrosinase inhibitor; apply only to hyperpigmented spots; limit to 3-4 months continuous use to avoid ochronosis (especially in skin of color). Prescription-strength 4% preferred.
- Tranexamic acid 5% topical - emerging evidence; inhibits plasminogen/melanocyte pathway; comparable to azelaic acid in RCTs for acne-induced PIH.
- Kojic acid 1-4% - tyrosinase inhibitor; OTC/Rx combinations.
2024 evidence note: A 2024 RCT found 20% azelaic acid cream comparable to 5% tranexamic acid solution for post-inflammatory hyperpigmentation in acne vulgaris.
Step 3 - Systemic Options (Moderate-Severe Acne)
| Agent | Role |
|---|---|
| Doxycycline 100mg OD/BD (max 3 months) | Oral antibiotic - strong AAD 2024 recommendation; always co-prescribe with BPO to prevent resistance |
| Minocycline 100mg OD | Alternative (conditional AAD 2024) |
| Isotretinoin | For severe/nodular/scarring truncal acne; resolves active disease and prevents new PIH formation |
| Hormonal therapy (females) | COCP (e.g., combined drospirenone/EE) or spironolactone for hormonal component |
Step 4 - Photoprotection (Non-Negotiable for PIH)
Sunscreen SPF 30 or higher daily to the trunk - UV exposure darkens PIH markedly. This is often overlooked for truncal PIH vs. the face. Non-comedogenic formulations only.
Step 5 - In-Office/Adjunct Procedures (Resistant PIH)
A 2024 systematic review (Kashetsky et al., JEADV) found that combination modalities produced the highest partial response rates (85%) vs. topicals alone (72%) or lasers alone (61%) for PIH. Complete response remains uncommon with any modality.
- Chemical peels - salicylic acid 20-30% peel series (every 3-4 weeks); glycolic acid 30-70% peels. Caution in darker skin tones (Fitzpatrick IV-VI) due to risk of worsening PIH.
- Microneedling - useful for combined PIH + textural changes/scarring.
- Lasers (Q-switched Nd:YAG, fractional lasers) - reserve for topical-resistant PIH; higher risk of worsening in Fitzpatrick IV-VI. Use lasers cautiously on the trunk - slower healing than face.
Practical Prescription Template (Moderate Truncal Acne + PIH, Fitzpatrick II-IV)
Rx 1: Trifarotene 0.005% cream (Aklief) - apply OD to entire affected trunk at night
Rx 2: BPO 5% wash - use in shower, leave on 2 min, rinse; daily
Rx 3: Azelaic acid 15% gel (Finacea) - apply OD to hyperpigmented spots, AM
Rx 4: Doxycycline 100mg - OD with food x 12 weeks (if moderate-severe)
OTC: Niacinamide 5% serum - apply to PIH areas AM
OTC: SPF 30+ non-comedogenic sunscreen - apply to entire trunk daily
Counsel: No picking/squeezing (major cause of new PIH). Avoid tight/occlusive synthetic clothing on active lesions. Expect 3-4 months for significant PIH improvement.
Key Evidence References
- Dermatology 2-Volume Set 5e (Elsevier), Treatment of Acne Vulgaris table + topical therapy tips
- 2024 AAD Guidelines for Acne Vulgaris
- Kashetsky et al. (2024), JEADV - PIH systematic review - PMID 37843491: combination therapy has best partial response (85%), complete response still low across all modalities
- Conte S et al. Skin Therapy Lett 2024 - trifarotene for truncal acne-induced PIH
- Azelaic acid 2024 RCT: 15% gel effective for both post-inflammatory erythema and PIH in acne vulgaris
This is a shared conversation. Sign in to Orris to start your own chat.